Neurovascular Devices Market Size, Status, Share And Forecast By 2026
The Neurovascular Devices Market is forecasted to grow from USD 2.12 Billion in 2018
to USD 3.35 Billion by 2026, at a CAGR of 5.6%, during the forecast period. The
market is primarily driven by the growing target population for patients,
favorable medical reimbursements, expansion of healthcare infrastructure across
emerging markets, and increased market demand for effective neurovascular
devices.
Request free sample of this
research report at: https://www.reportsanddata.com/sample-enquiry-form/1348
Technological
advances have increased life expectancy, resulting in an increase in geriatric
population as a consequence. The geriatric population (age 60 & above) is
projected to increase by 57% from 902 million in 2015 to 1.41 Billion by 2030,
according to a report published by the United Nations. As a result, the aging
population around the globe is expected to rise to boost demand for
neurovascular devices.
Neurovascular
therapy technological developments, such as the development of GORE TIGRIS by W
L Gore and Medtronic distal filter embolic protection device SpiderFX, are
expected to serve as a high impact rendering driver. It is expected that
inclination for minimally invasive surgery in brain aneurysm and stroke
treatments will be the key factor that will increase market growth.
Increasing
numbers of neurovascular therapy research, increased demand for minimally
invasive neurochirurgical procedures, and increased awareness for minimally
invasive surgical procedures among neurochirurgists provide significant market
growth opportunities. However, strict regulatory scenario and skilled
neurosurgeon dearth may hinder the growth of the market during the forecast
period.
To identify the key trends in the
industry, click on the link below: https://www.reportsanddata.com/report-detail/neurovascular-devices-market
Further
key findings from the report suggest
- The
Neurovascular Devices Market is forecasted to grow from USD 2.12 Billion
in 2018 to USD 3.35 Billion by 2026, at a CAGR of 5.6%, during the
forecast period. The market is primarily driven by the growing target
population for patients, favorable medical reimbursements, expansion of
healthcare infrastructure across emerging markets, and increased market
demand for effective neurovascular devices.
- The
market for cerebral embolization and aneurysm coiling devices is expected
to grow the largest at USD 1.11 Billion in 2026, at a CAGR of 6.5% during
the forecast period. Growing geriatric population and cerebrovascular
disorder prevalence are likely to encourage segment development. Cerebral
angiography involves using contrast colors and X-rays to monitor blood
flow through the brain. Products for neurothrombectomy are used in
patients who are ineligible for activator therapy for tissue plasminogen.
- The
market for stroke is expected to grow the largest at USD 1.91 Billion in
2026, at a CAGR of 6.1% during the forecast period. Motor impairment,
which causes movement disabilities, is the most common outcome associated
with stroke. The primary focus in stroke rehabilitation with the help of
stents and embolization coils is the recovery of lost artery functions.
- In
2018, North America dominated the market for Neurovascular devices. The
market for North America is expected to reach USD 1.21 Billion in 2026, at
a CAGR of 6% during the forecast period. Key factors driving this growth
include a favorable reimbursement structure, particularly in the U.S.,
large-scale R&D investments, and wide use of neurochirurgical products
supported by the availability of advanced technologies with higher
efficiency and confidence.
- The
major players in the market are W. L. Gore & Associates, Inc. (US),
Terumo Corp. (Japan), Abbott Laboratories (US), Merit Medical Systems,
Inc. (US), Medtronic Plc (Ireland), Penumbra, Inc. (US), Stryker Corp.
(US), Johnson & Johnson (US), MicroPort Scientific Corp. (China) and
others.
Comments
Post a Comment